Drugdiscovery >> Drug Development >> News
5861
Views
title
The uncertain fate of the Orphan Drug Tax Credit - drugdiscovery.com


USA tax reform coming in the fall could lead to elimination of the Orphan Drug Tax Credit, which is given to pharmaceutical companies for development of drugs for rare diseases. Biotech companies have aligned themselves with drug makers and patient advocacy groups to keep these tax credits alive.
Read More >>


Tags: orphan drug tax credit, orphan drug development, orphan drug - August 14, 2013
Related Articles
5643
Views
Orphan drug designation for DengueCide Orphan drug designation for DengueCide
FDA has approved orphan drug designation to DengueCide, NanoViricides’ drug candidate for the treatment of dengue and dengue hemorrhagic fever. Read More >>

Tags: DengueCide, dengue, hemorrhagic fever, drug,orphan drug, NanoViricides

4246
Views
New Orphan-Drug for the Treatment of Trigeminal Neuralgia New Orphan-Drug for the Treatment of Trigeminal Neuralgia
Convergence’s novel sodium channel blocker has been granted orphan-drug designation by the FDA. Read More >>

Tags: Trigeminal neuralgia, Convergence, sodium channel blocker

3204
Views
 GALE-401:  Galena Biopharma co-operates with Mills Pharmaceuticals GALE-401: Galena Biopharma co-operates with Mills Pharmaceuticals
Galena is a biophamraceutical company which is specialized on developing targeted oncology drugs. The company now co-operates with Mills Pharmaceuticals, who owns the rights to GALE-401, a new drug wh Read More >>

Tags: drug, orphan, Gale-401, Mills

8480
Views
FDA asks for input on antibiotic drug discovery FDA asks for input on antibiotic drug discovery
A US Food and Drug Administration (FDA) taskforce working on advancing antibiotic drug development has outlined its initial areas of interest, and proposed a list of pathogens that could trigger exte Read More >>

Tags: antibiotic drug development, FDA, drug candidate

5463
Views
Electric controll of drug can prevent side-effects Electric controll of drug can prevent side-effects
Several drugs have side effects because they are active in those parts of the body where they should not be. A group of scientists created a "smart" implant, which might solve this problem. Read More >>

Tags: smart implant, scientists, side effects, drug development, electronic drug control

4874
Views
GSK's diabetes Drug got an FDA 'okay' GSK's diabetes Drug got an FDA 'okay'
Taneum, the diabetes drug of GSK has been given a green light by FDA. With this 'okay' sign the pharmaceutical company can enter new markets. Read More >>

Tags: pharmatimes,pharma news, Eperzan, approved, albiglutide, Tanzeum, GSK, drug development, pain, diabetes, diabetes drug, new treatment for diabetes.

7702
Views
SOLIAIR™ - Breathing Made Easy! SOLIAIR™ - Breathing Made Easy!
SOLIAIR™ is a blend of botanical extracts and a food supplement that can help patients in chronic respiratory diseases such as Asthma, Bronchitis, COPD and other respiratory infections! Read More >>

Tags: Drug Development,Drug Discovery,Medicine Development,COPD Treatment,Asthma Solution,Bronchitis Therapy,Respiratory Diseases,Lung Infections,Breathing Disorders,healthcare investment,Drug Innovation,

2393
Views
Cytokinetics failed FDA's approval Cytokinetics failed FDA's approval
Cytokinetics' new ASÉ drug has failed clinical trials and was not approved by FDA. The drug has not reached the efficiency endpoint, therefore further research is going to be needed. Read More >>

Tags: drug, drug discovery, ASL drug, Cytokinetics asl drug, FDA approval, FDA approval of asl drugs.

10777
Views
New Pulmonary and Lung Diseases Solution! New Pulmonary and Lung Diseases Solution!
SOLIAIR™ is a food supplement which has reported beneficial impact. SOLIAIR™ can contribute to strengthening the respiratory system and may help patients in chronic respiratory diseases! Read More >>

Tags: Drug Development,Drug Discovery,Medicine Development,COPD Treatment,Asthma Solution,Bronchitis Therapy,Respiratory Diseases,Lung Infections,Breathing Disorders,healthcare investment,Drug Innovation,

2441
Views
Gilead has a new drug for HIV-1 infection Gilead has a new drug for HIV-1 infection
Gilead has announced that European Comission has accepted its new medicine, Vitekta. Te medicine includes ritonavir-boosted protease inhibitor - but what new things can it give to patients? Read More >>

Tags: patients, portease, drug, HIV

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013